Bonothyrk – Parathyroid Bioregulator
Bonothyrk delivers short-chain peptides that selectively interact with parathyroid tissue to maintain calcium-phosphorus homeostasis. Essential for bone mineral density, neuromuscular signalling, and hormonal equilibrium in the endocrine system.
Description
Bonothyrk is a precision-engineered bioregulator peptide that selectively targets parathyroid gland through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within parathyroid gland cells, Bonothyrk helps normalise calcium-phosphorus metabolism and parathyroid hormone regulation—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for endocrine tissue maintenance, making it a fundamentally different approach from conventional supplementation.